[Treatment of bronchial asthma in winter using controlled-release salbutamol].
This paper presents results about comparative study in winter season, in a statistics design AB and BA on 20 patients that were treated with salbutamol (Group B) and with salbutamol of controlled liberation (Group B) at random. Results showed that patients of Group B had improvement in symptomatology and had less exacerbations than those patients of group A with statistical significance. It was concluded that salbutamol tablets of controlled liberation is a therapeutic method adequate to control chronic phase of asthmatic patients in winter season.
Rico
F G
FG
Departamento de Neumología, Hospital General, Centro Médico, La Raza, IMSS.
Espinoza
J L
JL
Montero
P
P
Espinoza
F
F
Mancilla
A
A
Sánchez
A
A
Villanueva
C M
CM
D000293:Adolescent; D000328:Adult; D000420:Albuterol / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012621:Seasons
D003692:Delayed-Action Preparations; D000420:Albuterol
Tratamiento del asma bronquial en el periodo invernal con salbutamol de liberación controlada.